BJ
ECYT

BlackRock Japan’s Endocyte, Inc. Common Stock ECYT Stock Holding History

BlackRock Japan’s Portfolio ECYT Stock Details ECYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-4,939
Closed -$16K – 1475
2016
Q2 		$16K Sell
4,939
-1,241
-20% -$4.55K ﹤0.01% 1211
2016
Q1 		$19K Hold
6,180
– – ﹤0.01% 1195
2015
Q4 		$25K Hold
6,180
– – ﹤0.01% 1137
2015
Q3 		$28K Hold
6,180
– – ﹤0.01% 1058
2015
Q2 		$32K Hold
6,180
– – ﹤0.01% 1139
2015
Q1 		$39K Hold
6,180
– – ﹤0.01% 1110
2014
Q4 		$39K Buy
+6,180
New +$37.7K ﹤0.01% 1133

Other funds holding ECYT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
HCMT
Highland Capital Management (Texas) Dallas, Texas $39M AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock Japan's ECYT Position: Q3 2016 in Review

BlackRock Japan sold out of Endocyte, Inc. Common Stock (ECYT) in Q3 2016, closing a stake of 4,939 shares — an estimated $16K sold.

BlackRock Japan first reported a position in ECYT in Q4 2014 and held it in 7 quarters. The position peaked at $39K in Q1 2015. 90 funds tracked by Wall St. Rank hold ECYT as of Q3 2016.

  • BlackRock Japan reported no remaining Endocyte, Inc. Common Stock position as of Q3 2016 after selling out during the quarter.
  • BlackRock Japan sold 4,939 Endocyte, Inc. Common Stock shares in Q3 2016, an estimated $16K.
  • BlackRock Japan first reported a position in Endocyte, Inc. Common Stock in Q4 2014 and held it in 7 quarters.
  • BlackRock Japan's Endocyte, Inc. Common Stock position peaked at $39K in Q1 2015.
  • 90 funds tracked by Wall St. Rank held Endocyte, Inc. Common Stock as of Q3 2016.

Based on BlackRock Japan's 13F filing for Q3 2016, filed 8 Nov 2016.